169 related articles for article (PubMed ID: 527341)
21. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
Stanback J; Grimes D
Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
[TBL] [Abstract][Full Text] [Related]
22. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
23. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
Milsom I; Rybo G; Lindstedt G
Contraception; 1990 Mar; 41(3):271-81. PubMed ID: 2323218
[TBL] [Abstract][Full Text] [Related]
24. [The acceptability of current contraceptive methods to adolescents].
Sotnikova EI; Dubnitskaia LV; Perminova SG
Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
[TBL] [Abstract][Full Text] [Related]
25. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
Arowojolu AO; Otolorin EO; Ladipo OA
Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
[TBL] [Abstract][Full Text] [Related]
26. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
27. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
28. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
Andrade AT; de Souza JP; Rowe PJ; Shaw ST
Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
[TBL] [Abstract][Full Text] [Related]
29. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
Larsson B; Rodau S; Patek E
Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
[TBL] [Abstract][Full Text] [Related]
30. Selecting patients and inserting the Progestasert.
Soderstrom RM
Am J Gynecol Health; 1989; 3(3-S):17-8. PubMed ID: 12284993
[TBL] [Abstract][Full Text] [Related]
31. Menstrual blood loss in IUD users: comparative study of eleven different IUDs in Mexican women.
Pedron N
Adv Contracept Deliv Syst; 1995; 11(3-4):245-53. PubMed ID: 12290877
[TBL] [Abstract][Full Text] [Related]
32. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR).
Sivin I; Stern J
Fertil Steril; 1994 Jan; 61(1):70-7. PubMed ID: 8293847
[TBL] [Abstract][Full Text] [Related]
33. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
Malmqvist R; Petersohn L; Bengtsson LP
Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
[TBL] [Abstract][Full Text] [Related]
34. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
35. The rise and fall and rise of the IUD.
Burnhill MS
Am J Gynecol Health; 1989; 3(3-S):6-10. PubMed ID: 12285000
[TBL] [Abstract][Full Text] [Related]
36. Intrauterine devices.
Mccarthy TG; Ratnam SS
Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
[TBL] [Abstract][Full Text] [Related]
37. Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics.
Farr G; Amatya R; Betancourt JD; David M; Alfonso L; Dacalos E
Contraception; 1994 Nov; 50(5):417-29. PubMed ID: 7859451
[TBL] [Abstract][Full Text] [Related]
38. The intrauterine device today.
Rioux JE
J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529
[TBL] [Abstract][Full Text] [Related]
39. Serum cortisol level in lactating women using the Progestasert system.
Askalani H; Badraoui MH; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Contracept Deliv Syst; 1981 Apr; 2(1):133-8. PubMed ID: 12336865
[TBL] [Abstract][Full Text] [Related]
40. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
